Title:
MEDICAMENT FOR PREVENTING AND/OR TREATING SLEEP DISORDER
Document Type and Number:
WIPO Patent Application WO/2006/009093
Kind Code:
A1
Abstract:
Disclosed is a medicament for preventing and/or treating sleep disorders which contains a dibenzo[b,e]oxepin derivative represented by the formula (I) below or a pharmacologically acceptable salt thereof as an active constituent. (In the formula, R1, R2 and R3 may be the same or different and respectively represent a hydrogen atom or a lower alkyl group, and m and n may be the same or different and respectively represent an integer of 1-4.)
Inventors:
TANAKA HISAO
TANIGUCHI KOJI
TANIGUCHI KOJI
Application Number:
PCT/JP2005/013114
Publication Date:
January 26, 2006
Filing Date:
July 15, 2005
Export Citation:
Assignee:
KYOWA HAKKO KOGYO KK (JP)
TANAKA HISAO
TANIGUCHI KOJI
TANAKA HISAO
TANIGUCHI KOJI
International Classes:
A61K31/335; A61K31/00; A61P25/20; C07D313/12
Domestic Patent References:
| WO2003032912A2 | 2003-04-24 |
Other References:
KAMEI C ET AL: "Effect of epinastine hydrochloride (Alesion) on the central nervous system.", JAPANESE PHARMACOLOGY & THERAPEUTICS., vol. 30, no. 2, 2002, pages 91 - 95, XP002993045
SHIGEMOTO Y ET AL: "Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats.", EUROPEAN JOURNAL OF PHARMACOLOGY., vol. 294, no. 2-3, 28 July 2004 (2004-07-28), pages 161 - 165, XP002993046
SHIGEMOTO Y ET AL: "Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats.", EUROPEAN JOURNAL OF PHARMACOLOGY., vol. 294, no. 2-3, 28 July 2004 (2004-07-28), pages 161 - 165, XP002993046
Download PDF:
Previous Patent: METHOD OF EFFECTIVELY USING MEDICINE AND METHOD CONCERNING PREVENTION OF SIDE EFFECT
Next Patent: SOLENOID-CONTROLLED VALVE
Next Patent: SOLENOID-CONTROLLED VALVE